The National Agency for Food and Drug Administration and Control (NAFDAC) has warned the public over the circulation of unregistered and suspected counterfeit Colgate-branded toothpaste products.
In a statement posted on its X handle on Sunday, the agency said its Post-Marketing Surveillance Directorate received a complaint about the products being distributed in Kaduna State, prompting an immediate investigation.
NAFDAC officials, who visited the identified sales outlet, reportedly discovered two suspected counterfeit products labelled “Coglaet ActivGel 100g” and “Coglaet Herbal 100g.”
“The shop owner informed the team that the products were purchased from a door-to-door sales representative; however, no proof of purchase was provided,” the agency said.
NAFDAC added that the products had not met required regulatory standards for registration and quality assurance, warning that they pose potential risks to public health and safety.
The agency further disclosed that the items, including “Coglaet Crema Dental Herbal 100g” and “Coglaet ActivGel 100g,” carry no batch numbers or NAFDAC registration numbers.
It noted that the products were allegedly manufactured by Guangzhou YECAI Oral Cleaning Products Co., Ltd, located in Baiyun District, Guangzhou, China, with production dates of August 2025 and expiry dates of August 2029.
NAFDAC said the products have been withdrawn from circulation while investigations continue to trace distributors and prevent further spread.
It also directed all zonal directors and state coordinators to intensify surveillance and carry out mop-up operations nationwide.
The agency urged distributors, retailers, and consumers to exercise caution and verify the authenticity and physical condition of products before purchase or use.
Consumers were advised to report suspected counterfeit or substandard products to the nearest NAFDAC office, call 0800-162-3322, or email sf.alert@nafdac.gov.ng
.
NAFDAC also encouraged healthcare professionals and patients to report any adverse reactions via its official reporting platforms, including its website and the Med-Safety mobile application.
